Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2021

May 10, 2021

29821_dirs_2021-05-10_a9227159-d8c3-4ae8-8c0a-97f5f5dc7333.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-05-06

Reporting Person: Dockendorff Charles J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-06 Common Stock A 4763.0000 $0.0000 Acquired 37062.0000 Direct
2021-05-06 Common Stock A 2439.0000 $0.0000 Acquired 39501.0000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 40904.0000 Indirect

Footnotes

F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant.

F2: Restricted stock granted in lieu of 75% of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $105,000 divided by the closing price of common stock on the date of grant.